Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • FRAUD AND ABUSE—1st Cir.: No violation of constitutional rights where provider repeatedly requested to proceed pro se
    • ANTITRUST—E.D. Pa.: Summary judgment denied drug manufacturers in Niaspan® pay-for-delay litigation
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • EXPERT INSIGHTS—Peptides First, Paperwork Later: HHS Clears Six For Compounding Ahead Of Bulks List Rulemaking
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FEDERAL LEGISLATION NEWS—AI-Enabled Hacking Fuels Need to Renew Cyber Info-Sharing Law, Business Groups Say
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • GENERAL HEALTH CARE NEWS—FDA GUIDANCE NOTICES: FDA issues guidance on risk reduction of transfusion transmitted hepatitis B
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • HEALTH CARE EMPLOYMENT ISSUES—N.D. Ill.: Nurse forced to re-apply for job after hospital acquisition signed an enforceable arbitration agreement
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICAL DEVICES—FINAL RULES: FDA classifies certain radiology software
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PRESCRIPTION DRUGS—E.D. Mo.: West Virginia Pharmacy Audit Integrity Act does not provide a private right of action
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PRODUCTS LIABILITY (DEVICES)—D. Ariz.: Claims against Bard proceed to bellwether trial in patient’s implant injury case
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, GENERAL HEALTH CARE NEWS—FDA GUIDANCE NOTICES: FDA issues guidance on risk reduction of transfusion transmitted hepatitis B, (Nov 4, 2026)

    By WK Editorial Staff

    The FDA announced the availability of a final guidance titled “Recommendations for Reducing the Risk of Transfusion-Transmitted Hepatitis B Virus.”

    The guidance document provides blood establishments that collect blood and blood componen ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use